Die Forschung zu Seltenen Erkrankungen ist besonders wichtig. Viele dieser Erkrankungen verlaufen schwer und beeinträchtigen das Leben der Betroffenen erheblich. Deshalb ist es wichtig, ihre Ursachen besser zu verstehen und neue Behandlungsmöglichkeiten zu entwickeln.
Die Erkenntnisse aus der Forschung helfen nicht nur Menschen mit Seltenen Erkrankungen. Sie können auch dazu beitragen, andere, häufigere Erkrankungen besser zu verstehen und wirksamer zu behandeln.
DZKJ - Deutsches Zentrum für Kinder- und Jugendgesundheit
DZKJ - German Centre for Paediatric and Adolescent Medicine
Ulm Child Health (UCH) is an initiative of a group of departments at the University of Ulm that deal with child development and diseases and is coordinated by the renowned Department of Paediatrics.
UCH has successfully applied to participate in the German Centre for Child and Adolescent Health (DZKJ), a German Centre for Health Research (DZG) planned by the Federal Ministry of Education and Research (BMBF). The start-up phase is scheduled to begin in May 2024. In the DZKJ, UCH is only referred to as the DZKJ site in Ulm.
Partner am DZKJ-Standort sind die Universität Ulm, die Medizinische Fakultät der Universität Ulm, das Universitätsklinikum Ulm sowie das Institut für Klinische Transfusionsmedizin und Immungenetik Ulm des DRK-Blutspendedienstes. Am Standort Ulm arbeiten aktuell 24 DZKJ-Forschungsgruppen. Zu den Forschungsthemen gehört unter anderem die Forschung zu seltenen Erkrankungen. Eine Übersicht aller PIs des Standorts finden Sie hier.
Duale Lotsenstruktur zur Abklärung unklarer Diagnosen in Zentren für Seltene Erkrankungen
Dual pilot structure for clarifying unclear diagnoses in Centres for Rare Diseases / ZSE-DUO
The aim of the new form of care is to improve the treatment of people suspected of having a rare disease and thus increase the proportion of confirmed diagnoses.
In the ZSE-DUO project, 11 centres for rare diseases in Germany, the Allianz Chronischer Seltener Erkrankungen Achse e.V and health insurance companies are working closely together.
The project is funded by the Innovation Fund of the Joint Federal Committee.
Project start: 01.10.2018
Focal points: Rare diseases / psychosomatics / psychiatry
CORD MI
CORD MI
The "Collaboration on Rare Diseases" (CORD-MI) use case is a joint project comprising the four consortia of the Medical Informatics Initiative, in which numerous German university hospitals and partner institutions are involved. The aim is to improve care and research in the field of rare diseases.
Further information:
Use Case CORD-MI | Medical Informatics Initiative
Weitere Forschung
Further research
- Stem cell therapy for rare congenital bone marrow diseases
- Therapy for genetic dermatoses, rare collagenoses and collagenosis-related vasculitides or primary systemic vasculitides as well as tooth stabilisation in systemic scleroderma:
Therapy for genetic dermatoses Therapy for rare collagenoses and tooth stabilisation in systemic scleroderma
Therapy for collagenosis-related vasculitides
Therapy for primary systemic vasculitides - Tooth mobilisation for genetic tooth eruption disorders
- Slowing down progressive muscular dystrophy
- Gene therapy for spinal muscular atrophy
- Division of Pediatric Endocrinology and Diabetes:
www.uniklinik-ulm.de/kinder-und-jugendmedizin/forschung-research/prof-wabitsch-group.html